Balanced news tone
News Sentiment
TNG sentiment intelligence
Transgene SA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+0.3% over one week, -1.6% over four weeks, trend inactive, and below fair value.
Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC - Slideshow (OTCMKTS:TRGNF) 2026-07-01
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Transgene SA (TRGNF) Discusses Progress in Individualized Neoantigen Therapeutic Vaccines and Expansion into Early-Stage NSCLC - Slideshow (OTCMKTS:TRGNF) 2026-07-01
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Seeking Alpha
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Transgene Successfully Completes a Fundraising of c. €105 Million
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Nov 2025 08:00
- Source
- GlobeNewswire
AstraZeneca ties up with France's Transgene to develop viral immunotherapies
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 May 2019 07:00
- Source
- Reuters